These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28575570)

  • 1. [Aging of the myocardium and dilated cardiomyopathy: morphological and molecular aspects].
    Antonov IB; Kozlov KL; Linkova NS; Paltseva EM; Kykanova EO
    Adv Gerontol; 2017; 30(2):282-290. PubMed ID: 28575570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix Metalloproteinases MMP-1 and MMP-9 and Their Inhibitor TIMP-1 as Markers of Dilated Cardiomyopathy in Patients of Different Age.
    Antonov IB; Kozlov KL; Pal'tseva EM; Polyakova OV; Lin'kova NS
    Bull Exp Biol Med; 2018 Mar; 164(4):550-553. PubMed ID: 29504111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine Dilated Cardiomyopathy: Diffuse Remodeling, Focal Lesions, and the Involvement of Macrophages and New Vessel Formation.
    Gasparini S; Fonfara S; Kitz S; Hetzel U; Kipar A
    Vet Pathol; 2020 May; 57(3):397-408. PubMed ID: 32125251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, B⁺ tenascin-C and ED-A⁺ fibronectin in dilated cardiomyopathy: potential impact on disease progression and patients' prognosis.
    Franz M; Berndt A; Neri D; Galler K; Grün K; Porrmann C; Reinbothe F; Mall G; Schlattmann P; Renner A; Figulla HR; Jung C; Küthe F
    Int J Cardiol; 2013 Oct; 168(6):5344-51. PubMed ID: 23998545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles.
    Polyakova V; Loeffler I; Hein S; Miyagawa S; Piotrowska I; Dammer S; Risteli J; Schaper J; Kostin S
    Int J Cardiol; 2011 Aug; 151(1):18-33. PubMed ID: 20546954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced collagen accumulation and augmented MMP-2 activity in left ventricle of old rats submitted to high-intensity resistance training.
    Guzzoni V; Marqueti RC; Durigan JLQ; Faustino de Carvalho H; Lino RLB; Mekaro MS; Costa Santos TO; Mecawi AS; Rodrigues JA; Hord JM; Lawler JM; Davel AP; Selistre-de-Araújo HS
    J Appl Physiol (1985); 2017 Sep; 123(3):655-663. PubMed ID: 28684598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy.
    Herpel E; Pritsch M; Koch A; Dengler TJ; Schirmacher P; Schnabel PA
    Histopathology; 2006 May; 48(6):736-47. PubMed ID: 16681691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig.
    Goetzenich A; Hatam N; Zernecke A; Weber C; Czarnotta T; Autschbach R; Christiansen S
    J Heart Lung Transplant; 2009 Oct; 28(10):1087-93. PubMed ID: 19782292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase 9/neutrophil gelatinase associated lipocalin/tissue inhibitor of metalloproteinasess type 1 complexes are localized within cardiomyocytes and serve as a reservoir of active metalloproteinase in porcine female myocardium.
    Kiczak L; Tomaszek A; Bania J; Paslawska U; Zacharski M; Janiszewski A; Rybinska I; Dziegiel P; von Haehling S; Ardehali H; Jankowska EA; Ponikowski P
    J Physiol Pharmacol; 2014 Jun; 65(3):365-75. PubMed ID: 24930508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix Metalloproteinase 2 and 9 Enzymatic Activities are Selectively Increased in the Myocardium of Chronic Chagas Disease Cardiomyopathy Patients: Role of TIMPs.
    Baron MA; Ferreira LRP; Teixeira PC; Moretti AIS; Santos RHB; Frade AF; Kuramoto A; Debbas V; Benvenuti LA; Gaiotto FA; Bacal F; Pomerantzeff P; Chevillard C; Kalil J; Cunha-Neto E
    Front Cell Infect Microbiol; 2022; 12():836242. PubMed ID: 35372112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
    Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
    Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutis laxa: analysis of metalloproteinases and extracellular matrix expression by immunohistochemistry and histochemistry.
    Gu W; Liu W; Yang X; Yuan X; Tian Y; Meng R; Zhao Q
    Eur J Dermatol; 2011; 21(5):717-21. PubMed ID: 21719403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise training reduces fibrosis and matrix metalloproteinase dysregulation in the aging rat heart.
    Kwak HB; Kim JH; Joshi K; Yeh A; Martinez DA; Lawler JM
    FASEB J; 2011 Mar; 25(3):1106-17. PubMed ID: 21148111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of thrombospondin-2 causes age-related dilated cardiomyopathy.
    Swinnen M; Vanhoutte D; Van Almen GC; Hamdani N; Schellings MW; D'hooge J; Van der Velden J; Weaver MS; Sage EH; Bornstein P; Verheyen FK; VandenDriessche T; Chuah MK; Westermann D; Paulus WJ; Van de Werf F; Schroen B; Carmeliet P; Pinto YM; Heymans S
    Circulation; 2009 Oct; 120(16):1585-97. PubMed ID: 19805649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial collagen turnover in hypertrophic cardiomyopathy.
    Lombardi R; Betocchi S; Losi MA; Tocchetti CG; Aversa M; Miranda M; D'Alessandro G; Cacace A; Ciampi Q; Chiariello M
    Circulation; 2003 Sep; 108(12):1455-60. PubMed ID: 12952838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen I and III, MMP-1 and TIMP-1 immunoexpression in dilated cardiomyopathy.
    Mihailovici AR; Deliu RC; Mărgăritescu C; Simionescu CE; Donoiu I; Istrătoaie O; Tudoraşcu DR; Târtea EA; Gheonea DI
    Rom J Morphol Embryol; 2017; 58(3):777-781. PubMed ID: 29250654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.